# | Drug | Count |
---|---|---|
0 | PREDNISONE | 39 |
1 | METHOTREXATE | 37 |
2 | METHOTREXATE SODIUM | 37 |
3 | MYCOPHENOLATE MOFETIL | 30 |
4 | TACROLIMUS | 28 |
5 | PREDNISOLONE | 26 |
6 | ADALIMUMAB | 25 |
7 | CLOZAPINE | 22 |
8 | TACROLIMUS CAPSULES | 22 |
9 | AMLODIPINE | 20 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | CEFOTETAN DISODIUM | 1 | 0.0102 |
1 | INFLIXIMAB-AXXQ | 1 | 0.0102 |
2 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0069 |
3 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 1 | 0.0062 |
4 | ISRADIPINE | 2 | 0.0048 |
5 | VINBLASTINE SULFATE | 4 | 0.0030 |
6 | I.V. FAT EMULSION | 1 | 0.0020 |
7 | SORBITOL | 1 | 0.0020 |
8 | FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, SUCCINIC ACID, AND INTRINSIC FACTOR | 1 | 0.0018 |
9 | NELARABINE | 1 | 0.0017 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Immunoglobulin G [EPC] | 4 | 0.0007 |
1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 10 | 0.0006 |
2 | Lipid Emulsion [EPC] | 1 | 0.0006 |
3 | Interleukin-1 Receptor Antagonist [EPC] | 5 | 0.0005 |
4 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0005 |
5 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0004 |
6 | Sulfonamide Antibacterial [EPC] | 1 | 0.0004 |
7 | Alkaloid [EPC] | 6 | 0.0003 |
8 | Ergot Derivative [EPC] | 1 | 0.0003 |
9 | Cannabinoid [EPC] | 2 | 0.0003 |